Biocare Medical Is Once Again Named One of America’s Fastest-Growing Private Companies on Inc. Magazine’s Exclusive List, Inc. 500|5000

Biocare Medical Ranks No. 2781 on the 2011 Inc. 500 | 5000 with Three-Year Sales Growth of 79% Concord, CA, October 10, 2011 – Biocare Medical ranked No. 2781 in Inc. Magazine’s fifth annual Inc. 500|5000, an exclusive ranking of the nation’s fastest-growing private companies. This represents the third consecutive year that Biocare Medical has […]

Biocare Medical Launches a New Monoclonal PAX8 Antibody; Exhibiting Higher Specificity and Sharper Staining

Biocare Medical is proud to announce the launch of a mouse monoclonal PAX8 antibody. Unlike current existing PAX8 polyclonals, the PAX8 mouse clone [BC12] has been designed for specific epitope targeting. The monoclonal PAX8 does not stain B-cells, cells of pancreatic origin or neuroendocrine cells of the stomach or colon. This antibody also has lower […]

Biocare Medical launches a highly specific six antibody panel for differentiation of adenocarcinoma vs. squamous cell carcinoma of the lung

Biocare Medical is proud to announce the launch of the PulmoPanel™ Multiplex IHC to clearly differentiate between adenocarcinoma (LADC) and squamous cell carcinoma (SqCC) of the lung with 97% specificity and 93% sensitivity. This Multiplex IHC contains six antibodies (TTF-1, Napsin A, p63, TRIM29, Desmoglein 3 and CK5), and aids in the critical differentiation of […]

Biocare Medical Announces Agreement with Morphotek®, Inc. To Develop and Commercialize A Diagnostic Kit for Detection of Folate Receptor Alpha in Malignant Tissues

Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it has entered into a collaboration and license agreement with Biocare Medical, LLC. Under the agreement, the parties will collaborate to develop and commercialize an immunohistochemical (IHC) diagnostic kit utilizing Morphotek’s proprietary monoclonal antibody to specifically detect human folate receptor alpha (FRA) with Biocare’s intelliPATH™ […]

Biocare Medical launches a highly specific ERG monoclonal antibody to detect prevalent oncogenic alterations in prostate cancer

Biocare Medical is proud to announce the launch of the anti-ERG monoclonal antibody (clone 9FY CPDR) for in-vitro diagnostics, prognostics, patient monitoring, and screening by immunohistochemistry. The ERG oncoprotein is a promising diagnostic marker for identifying prostatic adenocarcinoma and distinguishing it from non-neoplastic prostate and other adenocarcinomas. This ERG antibody is 99.6% specific for prostate […]

Biocare Medical expands its Promark™ product line to canine applications.

Biocare Medical proudly introduces two newly developed HRP-Polymer detection systems, the Mouse-on-Canine HRP-Polymer and Rabbit-on-Canine HRP-Polymer. These polymers are specifically designed to achieve excellent staining quality when using mouse or rabbit primary antibodies on canine tissues. This addition to Biocare’s Promark series expands IHC detection applications to a broader range of animal tissues, resulting in […]

Biocare Medical launches Two New and Unique Chromogens – Improving Diagnostic Clarity

Biocare Medical is proud to present Vina Green Chromogen to the clinical diagnostic and research markets. The advanced formulation of Vina Green provides stable and vivid staining quality. The chromogen is a two-component system that produces a green stain in the presence of horseradish peroxidase. Vina Green is clearly distinguishable from Warp Red and DAB […]

Biocare Medical and the Henry M Jackson Foundation for the Advancement of Military Medicine Announce Exclusive Distribution Agreement for a Highly Specific ERG Monoclonal Antibody to Detect Prevalent Oncogenic Alterations in Prostate Cancer

Biocare Medical is proud to announce a licensing agreement with The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) for the exclusive world wide sales and distribution rights of the anti-ERG monoclonal antibody (clone 9FY – the CPDR ERG- MAb) for in-vitro diagnostics, prognostics, patient monitoring, and screening by immunohistochemistry. In […]

Biocare Medical launches Warp Red chromogen – The Faster, Sharper, More stable chromogen

The newly formulated Warp Red is a fast, sensitive and more stable alternative to conventional Fast Red chromogens. Warp Red features an accelerated chromogenic reaction, three times faster than Vulcan Fast Red (VFR); a 5-7minute incubation with Warp Red results in an equivalent or superior staining as VFR after 20minutes incubation. A sharper and more […]

Biocare Wins Top of the Class 2010 – Histology & Automated Pathology

Biocare Medical is highly honored to accept the “Top of the Class” awards for both Histology and Automated Pathology* for 2010. These awards recognize our commitment to patient care and the highest quality Molecular Pathology and IHC products. Biocare is dedicated to improving patient care by providing products for early and accurate cancer diagnosis and […]

Email Cart